Template:PDB Gallery/2152

Source: Wikipedia, the free encyclopedia.
  • 1ahw: A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
    1ahw: A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
  • 1boy: EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR
    1boy: EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR
  • 1dan: COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR
    1dan: COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR
  • 1fak: HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
    1fak: HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
  • 1j9c: Crystal Structure of tissue factor-factor VIIa complex
    1j9c: Crystal Structure of tissue factor-factor VIIa complex
  • 1jps: Crystal structure of tissue factor in complex with humanized Fab D3h44
    1jps: Crystal structure of tissue factor in complex with humanized Fab D3h44
  • 1o5d: Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
    1o5d: Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
  • 1tfh: EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
    1tfh: EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
  • 1uj3: Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor
    1uj3: Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor
  • 1w0y: TF7A_3771 COMPLEX
    1w0y: TF7A_3771 COMPLEX
  • 1w2k: TF7A_4380 COMPLEX
    1w2k: TF7A_4380 COMPLEX
  • 1wqv: Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine
    1wqv: Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine
  • 1wss: Human Factor Viia-Tissue Factor in Complex with peprid mimetic inhibitor that has two charge groups in P2 and P4
    1wss: Human Factor Viia-Tissue Factor in Complex with peprid mimetic inhibitor that has two charge groups in P2 and P4
  • 1wtg: Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine
    1wtg: Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine
  • 1wun: Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine
    1wun: Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine
  • 1wv7: Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine
    1wv7: Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine
  • 1z6j: Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor
    1z6j: Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor
  • 2a2q: Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+
    2a2q: Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+
  • 2aei: Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid
    2aei: Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid
  • 2aer: Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.
    2aer: Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.
  • 2b7d: Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model
    2b7d: Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model
  • 2b8o: Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex
    2b8o: Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex
  • 2c4f: CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121
    2c4f: CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121
  • 2f9b: Discovery of Novel Heterocyclic Factor VIIa Inhibitors
    2f9b: Discovery of Novel Heterocyclic Factor VIIa Inhibitors
  • 2fir: Crystal structure of DFPR-VIIa/sTF
    2fir: Crystal structure of DFPR-VIIa/sTF
  • 2flb: Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor
    2flb: Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor
  • 2flr: Novel 5-Azaindole Factor VIIa Inhibitors
    2flr: Novel 5-Azaindole Factor VIIa Inhibitors
  • 2hft: THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION
    2hft: THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION
  • 2puq: Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor
    2puq: Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor